ESTUDIO DE BIOEQUIVALENCIA DE FORMULACIÓN DE PRUEBA Fibroneurina y la formulación de referencia de prueba Fingolimed 0.5 mg. Cépsulas duras en condición de ayuno
Bioequivalence Study of Test Formulation Fibroneurina and Reference Formulation Fingolimod 0.5 mg hard capsules under fasting conditions
Prensa méd. argent; 103 (9), 2017
Conclusion Bioequivalence Results:
A total of 40 subjects were planned
and enrolled in the study. Thirty-nine
(39) subjects completed the clinical phase
of the study and data of thirty-nine (39)
subjects were considered for pharmacokinetic and statistical analysis.
The 90 % CI’s of Ln-transformed
param...